Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade.

Oberaigner W, Minicozzi P, Bielska-Lasota M, Allemani C, de Angelis R, Mangone L, Sant M; Eurocare Working Group.

Acta Oncol. 2012 Apr;51(4):441-53. doi: 10.3109/0284186X.2011.653437. Epub 2012 Feb 7.

PMID:
22313338
2.

Survival of ovarian cancer in Iran: 2000-2004.

Arab M, Khayamzadeh M, Mohit M, Hosseini M, Anbiaee R, Tabatabaeefar M, Ebrahimi M, Tehranian A, Akbari ME.

Asian Pac J Cancer Prev. 2009 Oct-Dec;10(4):555-8.

3.

Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer.

Kim SJ, Rosen B, Fan I, Ivanova A, McLaughlin JR, Risch H, Narod SA, Kotsopoulos J.

Br J Cancer. 2017 Mar 28;116(7):964-971. doi: 10.1038/bjc.2017.35. Epub 2017 Feb 16.

4.

Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma?

Moss EL, Evans T, Pearmain P, Askew S, Singh K, Chan KK, Ganesan R, Hirschowitz L.

Int J Gynecol Cancer. 2015 Sep;25(7):1201-7. doi: 10.1097/IGC.0000000000000477.

PMID:
26035124
5.

Italian cancer figures--Report 2015: The burden of rare cancers in Italy.

AIRTUM Working Group, Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, Bella F, Amodio R, Bizzoco S, Cassetti T, Cirilli C, Cusimano R, De Angelis R, Fusco M, Gatta G, Gennaro V, Giacomin A, Giorgi Rossi P, Mangone L, Mannino S, Rossi S, Pierannunzio D, Tavilla A, Tognazzo S, Tumino R, Vicentini M, Vitale MF, Crocetti E, Dal Maso L.

Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Erratum in: Epidemiol Prev. 2016 Mar-Apr;40(2):83.

6.

Impact of prognostic factors on survival rates in patients with ovarian carcinoma.

Arikan SK, Kasap B, Yetimalar H, Yildiz A, Sakarya DK, Tatar S.

Asian Pac J Cancer Prev. 2014;15(15):6087-94.

7.

Epidemiologic features of borderline ovarian tumors in California: a population-based study.

Morris CR, Liu L, Rodriguez AO, Cress RD, Snipes K.

Cancer Causes Control. 2013 Apr;24(4):665-74. doi: 10.1007/s10552-013-0145-9. Epub 2013 Jan 13.

PMID:
23314731
8.

Survival of Patients With Mucinous Ovarian Carcinoma and Ovarian Metastases: A Population-Based Cancer Registry Study.

Simons M, Ezendam N, Bulten J, Nagtegaal I, Massuger L.

Int J Gynecol Cancer. 2015 Sep;25(7):1208-15. doi: 10.1097/IGC.0000000000000473.

PMID:
25978291
9.

Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.

Gasimli K, Braicu EI, Nassir M, Richter R, Babayeva A, Chekerov R, Darb-Esfahani S, Sehouli J, Muallem MZ.

Ann Surg Oncol. 2016 Apr;23(4):1279-86. doi: 10.1245/s10434-015-4959-4. Epub 2016 Jan 29.

PMID:
26832880
10.

Prognostic factors and clinical outcome of patients with recurrent early-stage epithelial ovarian cancer: an Italian multicenter retrospective study.

Gadducci A, Cosio S, Zola P, Sostegni B, Fuso L, Sartori E.

Int J Gynecol Cancer. 2013 Mar;23(3):461-8. doi: 10.1097/IGC.0b013e318286665b.

PMID:
23370604
11.

Does omentectomy in epithelial ovarian cancer affect survival? An analysis of the Surveillance, Epidemiology, and End Results database.

McNally L, Teng NN, Kapp DS, Karam A.

Int J Gynecol Cancer. 2015 May;25(4):607-15. doi: 10.1097/IGC.0000000000000412.

PMID:
25756404
12.

Low-dose aspirin use and the risk of ovarian cancer in Denmark.

Baandrup L, Kjaer SK, Olsen JH, Dehlendorff C, Friis S.

Ann Oncol. 2015 Apr;26(4):787-92. doi: 10.1093/annonc/mdu578. Epub 2014 Dec 23.

PMID:
25538177
13.

Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancer.

Fehm T, Banys M, Rack B, Janni W, Marth C, Blassl C, Hartkopf A, Trope C, Kimmig R, Krawczyk N, Wallwiener D, Wimberger P, Kasimir-Bauer S.

Int J Gynecol Cancer. 2013 Jun;23(5):839-45. doi: 10.1097/IGC.0b013e3182907109.

PMID:
23694981
14.

Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancer.

Nielsen JS, Jakobsen E, Hølund B, Bertelsen K, Jakobsen A.

Int J Gynecol Cancer. 2004 Nov-Dec;14(6):1086-96.

PMID:
15571614
15.

"The impact of debulking surgery in patients with node-positive epithelial ovarian cancer: Analysis of prognostic factors related to overall survival and progression-free survival after an extended long-term follow-up period".

Pereira A, Pérez-Medina T, Magrina JF, Magtibay PM, Rodríguez-Tapia A, Cuesta-Guardiola T, Peregrin I, Mendizabal E, Lizarraga S, Ortiz-Quintana L.

Surg Oncol. 2016 Mar;25(1):49-59. doi: 10.1016/j.suronc.2015.12.005. Epub 2016 Feb 10.

PMID:
26979641
16.

BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study.

Lesnock JL, Darcy KM, Tian C, Deloia JA, Thrall MM, Zahn C, Armstrong DK, Birrer MJ, Krivak TC.

Br J Cancer. 2013 Apr 2;108(6):1231-7. doi: 10.1038/bjc.2013.70. Epub 2013 Mar 5.

17.

Population attributable fractions for ovarian cancer in Swedish women by morphological type.

Granström C, Sundquist J, Hemminki K.

Br J Cancer. 2008 Jan 15;98(1):199-205. Epub 2007 Dec 11.

18.

Hormone receptors and ovarian cancer survival.

Gourley C.

Lancet Oncol. 2013 Aug;14(9):794-5. doi: 10.1016/S1470-2045(13)70323-1. Epub 2013 Jul 9. No abstract available.

PMID:
23845224
19.

Prognostic factors for ovarian epithelial cancer in the elderly: a case-control study.

Sabatier R, Calderon B Jr, Lambaudie E, Chereau E, Provansal M, Cappiello MA, Viens P, Rousseau F.

Int J Gynecol Cancer. 2015 Jun;25(5):815-22. doi: 10.1097/IGC.0000000000000418.

PMID:
25768081
20.

A detailed study of patients and tumor characteristics of epithelial ovarian cancer in Saudi women.

Al-Badawi IA, Munkarah AR, Tulbah A, Babic II, Al Husaini H, Ahmad S.

Int J Gynecol Cancer. 2013 Mar;23(3):456-60. doi: 10.1097/IGC.0b013e318284aafe.

PMID:
23360812

Supplemental Content

Support Center